GRAIL, Inc.(GRAL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GRAL GRAIL, Inc.

未开盘 09-30 16:00:00 EDT

140.12

+3.55

+2.60%

盘后139.86

-0.26-0.19%

19:56 EDT

最高151.46	最低136.00	成交量192.38万
今开138.27	昨收136.57	日振幅11.32%
总市值62.59亿	流通市值57.02亿	总股本4,467万
成交额2.78亿	换手率4.73%	流通股本4,070万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GRAL","market":"US","secType":"STK","nameCN":"GRAIL, Inc.","latestPrice":140.12,"timestamp":1790798400000,"preClose":136.57,"halted":0,"volume":1923794,"hourTrading":{"tag":"盘后","latestPrice":139.86,"preClose":140.12,"latestTime":"19:56 EDT","volume":32521,"amount":4558526.3976,"timestamp":1790812614555,"change":-0.26,"changeRate":-0.001856,"amplitude":0.00865},"delay":0,"changeRate":0.025993995753093736,"floatShares":40696402,"shares":44666200,"eps":-9.748709,"marketStatus":"未开盘","change":3.55,"latestTime":"09-30 16:00:00 EDT","open":138.27,"high":151.4574,"low":136,"amount":277625751.73451996,"amplitude":0.113183,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-9.748709,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1790841600000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":136.57,"preHourTrading":{"tag":"盘前","latestPrice":138.27,"preClose":136.57,"latestTime":"09:29 EDT","volume":1003,"amount":136083.05809,"timestamp":1790774941030,"change":1.7,"changeRate":0.012448,"amplitude":0.045911},"postHourTrading":{"tag":"盘后","latestPrice":139.86,"preClose":140.12,"latestTime":"19:56 EDT","volume":32521,"amount":4558526.3976,"timestamp":1790812614555,"change":-0.26,"changeRate":-0.001856,"amplitude":0.00865},"volumeRatio":0.958668,"impliedVol":0.8926,"impliedVolPercentile":0.3506},"requestUrl":"/m/hq/s/GRAL","defaultTab":"news","newsList":[{"id":"1100526236","title":"异动解读｜GRAIL盘中上涨5.27%，FDA顾问委员会全票通过Galleri安全性并支持获批","url":"https://stock-news.laohu8.com/highlight/detail?id=1100526236","media":"行情直击","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100526236?lang=zh_cn&edition=full","pubTime":"2026-09-30 22:07","pubTimestamp":1790777220,"startTime":"0","endTime":"0","summary":"消息面上，FDA分子与临床遗传学器械顾问委员会此前就GRAIL旗下Galleri多癌种早期检测产品的上市前批准申请进行投票，10名委员以10:0全票通过安全性，6:4通过有效性，7:2认定该产品对50岁及以上成人的临床获益大于风险。此前PATHFINDER 2研究显示，Galleri联合常规筛查可将癌症检出率提升6.5倍，71%的新发现癌症处于I至III期。瑞银维持买入评级，认为顾问委员会的积极投票几乎\"消除了风险\"，市场对Galleri正式获批的预期持续升温，推动股价自9月下旬以来大幅走高。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"FDA顾问委员会全票通过，GRAIL上涨","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194948486","title":"异动解读｜GRAIL盘中上涨5.69%，FDA顾问委员会投票支持Galleri癌症检测获批","url":"https://stock-news.laohu8.com/highlight/detail?id=1194948486","media":"行情直击","labels":["corporation","policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1194948486?lang=zh_cn&edition=full","pubTime":"2026-09-28 21:45","pubTimestamp":1790603132,"startTime":"0","endTime":"0","summary":"9月28日，GRAIL盘中上涨5.69%，报130.765美元/股，成交额1775.57万美元。消息面上，FDA分子与临床遗传学器械顾问委员会近日对GRAIL旗下Galleri多癌种早期检测产品的上市前批准申请进行投票，10名投票成员全票通过安全性，以6比4通过有效性，以7比2通过针对50岁及以上成人的获益-风险评估。顾问委员会的积极投票进一步推动市场对Galleri正式获批的乐观预期，股价延续近期上行趋势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"FDA顾问委员会支持，GRAIL盘中上涨","news_tag":"corporation,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199948635","title":"异动解读｜GRAIL盘中上涨5.97%，FDA顾问委员会投票支持Galleri癌症检测产品上市","url":"https://stock-news.laohu8.com/highlight/detail?id=1199948635","media":"行情直击","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1199948635?lang=zh_cn&edition=full","pubTime":"2026-09-24 21:58","pubTimestamp":1790258310,"startTime":"0","endTime":"0","summary":"消息面上，FDA医疗器械咨询委员会分子与临床遗传学设备小组对Galleri多癌种早期检测产品的上市前批准申请进行了投票，10名投票成员全票通过其安全性，以6比4支持其有效性，以7比2认可其在50岁及以上成人中检测多种癌症的获益-风险比。此前FDA简报文件显示，该机构对Galleri的分析性能、桥接分析及主要安全性数据无重大疑问，讨论焦点集中在产品标签定位上。顾问委员会的积极投票为后续FDA正式批准奠定了重要基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"FDA顾问委员会力挺，GRAIL盘中上涨","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134221217","title":"暗流涌动：GRAIL股价因FDA会议文件公布而飙升","url":"https://stock-news.laohu8.com/highlight/detail?id=1134221217","media":"投资观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1134221217?lang=zh_cn&edition=full","pubTime":"2026-09-22 06:58","pubTimestamp":1790031507,"startTime":"0","endTime":"0","summary":"周一，GRAIL公司股价大幅攀升34%，此轮涨势源于美国食品药品监督管理局在周四顾问委员会会议前夕发布了一系列文件。这些文件将对FDA是否批准该公司研发的多癌种血液检测产品起到决定性作用。自2021年起，GRAIL便以处方形式销售此产品，但FDA至今尚未批准任何一款用于筛查多种癌症的检测手段。然而，该检测对多数癌症病例未能及时发现。无论是上述美国研究，还是在涉及约14.2万人的英国试验中，Galleri仅能捕捉到约三分之一在一年内确诊的癌症病例。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4588","BK4585","GRAL","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180134132","title":"GRAIL宣布FDA咨询委员会会议将审议Galleri®多癌早检上市前申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1180134132","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1180134132?lang=zh_cn&edition=full","pubTime":"2026-08-07 23:06","pubTimestamp":1786115182,"startTime":"0","endTime":"0","summary":"GRAIL（股票代码：GRAL）正式对外披露，美国食品药品监督管理局（FDA）已计划召开一场咨询委员会会议，专门针对其旗下面向多癌种早期检测的Galleri®检测产品，所提交的上市前批准申请（PMA）进行深入审议。这一里程碑式的进展，标志着该潜在颠覆性癌症筛查技术，在通往监管绿灯的道路上，迈出了至关重要的一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191676874","title":"Priority Health携手GRAIL，成为密歇根州首个为雇主计划提供Galleri®多癌种早期检测血液测试的医疗计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1191676874","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191676874?lang=zh_cn&edition=full","pubTime":"2026-07-16 21:01","pubTimestamp":1784206891,"startTime":"0","endTime":"0","summary":"Priority Health与GRAIL, Inc.达成合作，开创密歇根州先河，成为该州首个将Galleri®多癌种早期检测血液测试纳入雇主医疗计划的健康保险机构。此项合作旨在通过前沿的液体活检技术，为参保员工提供更早发现多种癌症的机会，从而可能改善治疗结果并降低医疗成本。Galleri®测试能够通过单次抽血，筛查出50多种癌症的信号，其中包括许多缺乏常规筛查指南的癌症类型。这一举措标志着精准医疗和预防性健康管理在雇主福利领域的重要拓展，有望提升整体人群的健康水平。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104190016","title":"GRAIL在2026年ASCO年会上公布NHS-Galleri试验完整结果，显示晚期癌症诊断数量显著减少","url":"https://stock-news.laohu8.com/highlight/detail?id=1104190016","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1104190016?lang=zh_cn&edition=full","pubTime":"2026-05-30 20:01","pubTimestamp":1780142464,"startTime":"0","endTime":"0","summary":"GRAIL公司在2026年美国临床肿瘤学会（ASCO）年会上，正式公布了其NHS-Galleri试验的完整数据。该试验结果明确显示，通过其多癌种早期检测血液检测技术Galleri，能够显著降低第四期（晚期）癌症的诊断数量。这一关键数据进一步验证了该检测方法在癌症早期发现与干预方面的潜在价值，为改善癌症患者预后提供了新的有力证据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142483101","title":"财报前瞻｜GRAIL, Inc.本季度营收预计小幅增长，机构观点偏谨慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1142483101","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1142483101?lang=zh_cn&edition=full","pubTime":"2026-04-29 00:55","pubTimestamp":1777395357,"startTime":"0","endTime":"0","summary":"GRAIL, Inc.将于2026年05月05日美股盘后发布最新季度财报，市场关注收入增速能否延续、费用投放节奏与利润率改善。市场目前一致预期本季度GRAIL, Inc.营收为3,888.14万美元，同比增长10.46%；息税前亏损为1.26亿美元，同比增长11.44%；调整后每股收益为-2.76美元，同比增长32.45%。从近期针对GRAIL, Inc.的研究报道中，机构观点偏谨慎，关注点集中在收入增速放缓与费用投入的回报周期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻｜GRAIL, Inc.本季度营收预计小幅增长，机构观点偏谨慎","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518022743","title":"Grail, Inc.盘中异动 急速跳水5.38%报31.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518022743","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518022743?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:31","pubTimestamp":1741613489,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时31分，Grail, Inc.股票出现异动，股价快速下跌5.38%。截至发稿，该股报31.11美元/股，成交量2.6055万股，换手率0.08%，振幅0.94%。Grail, Inc.股票所在的生命科学行业中，整体跌幅为0.54%。Grail, Inc.公司简介：GRAIL Inc是一家医疗保健公司，致力于开发用于早期癌症检测的技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213129a26a246b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213129a26a246b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517613371","title":"Grail, Inc.盘中异动 早盘股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517613371","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517613371?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:38","pubTimestamp":1741271897,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时38分，Grail, Inc.股票出现异动，股价快速下挫5.08%。Grail, Inc.股票所在的生命科学行业中，整体涨幅为0.78%。其相关个股中，Fulgent Genetics, Inc.、安奈特保险、Bioaffinity Technologies, Inc.涨幅较大，Mainz Biomed N.V.、Endra Life Sciences Inc.、Ispecimen Inc.较为活跃，换手率分别为0.60%、0.47%、0.42%，振幅较大的相关个股有Bioaffinity Technologies, Inc.、Biodesix, Inc.、Check-Cap Ltd.，振幅分别为15.27%、10.31%、8.96%。Grail, Inc.公司简介：GRAIL Inc是一家医疗保健公司，致力于开发用于早期癌症检测的技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223818963c4e79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223818963c4e79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517946610","title":"Grail, Inc.盘中异动 快速上涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517946610","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517946610?lang=zh_cn&edition=full","pubTime":"2025-03-05 23:38","pubTimestamp":1741189101,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日23时38分，Grail, Inc.股票出现波动，股价急速上涨5.12%。截至发稿，该股报43.66美元/股，成交量32.5545万股，换手率0.96%，振幅7.10%。Grail, Inc.股票所在的生命科学行业中，整体涨幅为0.49%。其相关个股中，Neuronetics, Inc.、Oncocyte Corporation、Biodesix, Inc.涨幅较大，Neuronetics, Inc.、Ispecimen Inc.、Grail, Inc.较为活跃，换手率分别为2.12%、1.99%、0.98%，振幅较大的相关个股有Bioaffinity Technologies, Inc.、Neuronetics, Inc.、Oncocyte Corporation，振幅分别为17.70%、16.55%、15.98%。Grail, Inc.公司简介：GRAIL Inc是一家医疗保健公司，致力于开发用于早期癌症检测的技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305233821989d56b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305233821989d56b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516967735","title":"Grail, Inc.盘中异动 早盘急速下跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516967735","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516967735?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:31","pubTimestamp":1741098671,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时31分，Grail, Inc.股票出现异动，股价大幅下跌5.03%。截至发稿，该股报34.50美元/股，成交量2.064万股，换手率0.06%，振幅0.00%。Grail, Inc.股票所在的生命科学行业中，整体跌幅为0.05%。其相关个股中，Prenetics Global、Mainz Biomed N.V.、Neuronetics, Inc.涨幅较大，Biodesix, Inc.、Ispecimen Inc.、Natera, Inc.较为活跃，换手率分别为2.00%、0.77%、0.66%，振幅较大的相关个股有Xwell, Inc.、Mdxhealth Sa、Applied Dna Sciences, Inc.，振幅分别为3.25%、2.92%、1.44%。Grail, Inc.公司简介：GRAIL Inc是一家医疗保健公司，致力于开发用于早期癌症检测的技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223111a25f03ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223111a25f03ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514335555","title":"Grail, Inc.盘中异动 股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514335555","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514335555?lang=zh_cn&edition=full","pubTime":"2025-02-28 01:51","pubTimestamp":1740678661,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日01时51分，Grail, Inc.股票出现波动，股价急速下跌5.03%。截至发稿，该股报41.66美元/股，成交量44.1125万股，换手率1.30%，振幅9.53%。Grail, Inc.股票所在的生命科学行业中，整体跌幅为0.96%。Grail, Inc.公司简介：GRAIL Inc是一家医疗保健公司，致力于开发用于早期癌症检测的技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228015101abdf9c65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228015101abdf9c65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514859066","title":"Grail, Inc.盘中异动 大幅上涨5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514859066","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514859066?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:59","pubTimestamp":1740581955,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时59分，Grail, Inc.股票出现异动，股价大幅上涨5.36%。Grail, Inc.股票所在的生命科学行业中，整体涨幅为0.06%。其相关个股中，Neuronetics, Inc.、Bioaffinity Technologies Inc C/Wts 07/09/2027 、Guardant Health, Inc.涨幅较大，Prophase Labs, Inc.、Ispecimen Inc.、Mainz Biomed N.V.较为活跃，换手率分别为6.26%、2.70%、1.77%，振幅较大的相关个股有Genedx Holdings Corp C/Wts 22/07/2026 、Prophase Labs, Inc.、Bioaffinity Technologies, Inc.，振幅分别为14.68%、13.69%、9.23%。Grail, Inc.公司简介：GRAIL Inc是一家医疗保健公司，致力于开发用于早期癌症检测的技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226225915963154cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226225915963154cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513722748","title":"Grail, Inc.盘中异动 早盘股价大涨5.16%报42.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513722748","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513722748?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:34","pubTimestamp":1740407655,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时34分，Grail, Inc.股票出现波动，股价快速拉升5.16%。截至发稿，该股报42.83美元/股，成交量9.387万股，换手率0.28%，振幅9.18%。Grail, Inc.股票所在的生命科学行业中，整体涨幅为0.50%。Grail, Inc.公司简介：GRAIL Inc是一家医疗保健公司，致力于开发用于早期癌症检测的技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223415abdb0e67&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223415abdb0e67&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513756136","title":"Grail, Inc.2024财年实现净利润-20.27亿美元，同比减少38.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513756136","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513756136?lang=zh_cn&edition=full","pubTime":"2025-02-24 00:01","pubTimestamp":1740326472,"startTime":"0","endTime":"0","summary":"2月24日，Grail, Inc.公布财报，公告显示公司2024财年净利润为-20.27亿美元，同比减少38.27%；其中营业收入为1.26亿美元，同比增加35.32%，每股基本收益为-63.54美元。从资产负债表来看，Grail, Inc.总负债4.80亿美元，其中短期债务13.26百万美元，资产负债比为6.22，流动比率为0.11。机构评级：截至2025年2月24日，当前有1家机构对Grail, Inc.目标价做出预测，其中目标均价为16.00美元，其中最低目标价为16.00美元，最高目标价为16.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224000143a250ce17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224000143a250ce17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513296599","title":"Grail, Inc.盘中异动 早盘股价大跌5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513296599","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513296599?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:31","pubTimestamp":1740148287,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时31分，Grail, Inc.股票出现波动，股价急速跳水5.47%。Grail, Inc.股票所在的生命科学行业中，整体涨幅为0.17%。其相关个股中，Atlantic International Corp.、Prophase Labs, Inc.、安奈特保险涨幅较大，Prophase Labs, Inc.、Mainz Biomed N.V.、Precipio, Inc.较为活跃，换手率分别为6.96%、0.94%、0.28%，振幅较大的相关个股有Grail, Inc.、Neuronetics, Inc.、Prophase Labs, Inc.，振幅分别为7.54%、5.25%、4.88%。Grail, Inc.公司简介：GRAIL Inc是一家医疗保健公司，致力于开发用于早期癌症检测的技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223127962b7b39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223127962b7b39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194870684","title":"异动解读 | 单季销售额增长超出预期,GRAIL公司盘前股价大涨7.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=1194870684","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1194870684?lang=zh_cn&edition=full","pubTime":"2025-02-21 17:32","pubTimestamp":1740130335,"startTime":"0","endTime":"0","summary":"生物科技公司GRAIL(GRAL)今日盘前股价大涨7.01%,引发市场广泛关注。\n\n公司第四季度财报显示,虽然GRAIL仍处于亏损状态,但季度销售额同比大幅增长26.14%,超越市场预期。分析人士指出,尽管生物科技公司在产品研发初期常常面临亏损,但强劲的销售额增长预示着GRAIL产品的广阔市场前景,反映出公司在主营业务上取得了进展。\n\n因此,市场对GRAIL未来的长期增长潜力预期增强,从而推动公司股价在盘前大涨。生物科技公司的发展通常需要长期耐心,投资者关注公司是否能在业务层面取得实质性进展,而收入增长正是进展的重要体现。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170692542","title":"异动解读 | GRAIL夜盘大涨11.68%,销售额增长成亮点","url":"https://stock-news.laohu8.com/highlight/detail?id=1170692542","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1170692542?lang=zh_cn&edition=full","pubTime":"2025-02-21 14:52","pubTimestamp":1740120753,"startTime":"0","endTime":"0","summary":"生物科技公司GRAIL(GRAL)2月21日(周五)在纳斯达克夜盘交易中大涨11.68%,引发市场关注。\n\n消息显示,GRAIL此前公布的第四季度财报出现亏损,但销售额增长达26.14%,好于市场预期。强劲的收入增长成为该公司股价飙升的主要推手。\n\n分析人士指出,尽管生物科技公司往往在早期阶段存在亏损,但GRAIL销售额的快速增长预示着公司产品的广阔市场前景,反映出公司在主营业务上取得了进展,因而提振了投资者对GRAIL长期增长潜力的预期,推动股价大涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159692944","title":"异动解读 | GRAIL大涨16.73%,季度销售额同比大增","url":"https://stock-news.laohu8.com/highlight/detail?id=1159692944","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1159692944?lang=zh_cn&edition=full","pubTime":"2025-02-21 05:32","pubTimestamp":1740087142,"startTime":"0","endTime":"0","summary":"纳斯达克上市生物科技公司GRAIL今日盘后大涨16.73%,成为市场焦点。\n\n盘前,GRAIL公布了第四季度业绩。虽然该公司仍在亏损,但业绩超出预期:每股亏损2.89美元,同比收窄52.15%;季度销售额3825万美元,同比增长26.14%。\n\n销售额的强劲增长是推动GRAIL股价大涨的主要动力。分析人士指出,尽管生物科技公司在研发初期通常存在亏损,但GRAIL收入的快速增长预示着公司产品的广阔市场前景,反映出公司在主营业务上取得了进展。因此投资者对GRAIL的长期增长预期有所提升,从而推动股价上涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GRAL"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://grail.com;investors.grail.com","stockEarnings":[{"period":"1week","weight":0.2912},{"period":"1month","weight":0.7654},{"period":"3month","weight":1.0275},{"period":"6month","weight":1.5481},{"period":"1year","weight":1.3697},{"period":"ytd","weight":0.6371}],"compareEarnings":[{"period":"1week","weight":-0.0067},{"period":"1month","weight":-0.0058},{"period":"3month","weight":0.024},{"period":"6month","weight":0.1628},{"period":"1year","weight":0.1448},{"period":"ytd","weight":0.1184}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Grail, Inc.于2015年9月11日在特拉华州注册成立。该公司是一家医疗保健公司，致力于通过开创癌症早期检测的新技术来拯救生命和改善健康。该公司建立了一个由科学家、工程师和医生组成的多学科组织，它正利用下一代测序（NGS）、人群规模临床研究以及最先进的计算机科学和数据科学的力量来克服医学的最大挑战之一。该公司利用该公司的平台技术，开发了一种多癌症早期检测血液检测方法，在临床研究中证明了从一次抽血中就可以检测出50多种癌症类型，并能高度准确地定位癌症信号。","exchange":"NASDAQ","name":"GRAIL, Inc.","nameEN":"GRAIL, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GRAIL, Inc.(GRAL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供GRAIL, Inc.(GRAL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"GRAIL, Inc.,GRAL,GRAIL, Inc.股票,GRAIL, Inc.股票老虎,GRAIL, Inc.股票老虎国际,GRAIL, Inc.行情,GRAIL, Inc.股票行情,GRAIL, Inc.股价,GRAIL, Inc.股市,GRAIL, Inc.股票价格,GRAIL, Inc.股票交易,GRAIL, Inc.股票购买,GRAIL, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GRAIL, Inc.(GRAL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供GRAIL, Inc.(GRAL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}